GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Laboratories Ltd (BOM:539287) » Definitions » Cyclically Adjusted PB Ratio

Ortin Laboratories (BOM:539287) Cyclically Adjusted PB Ratio : 0.66 (As of Jun. 19, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ortin Laboratories Cyclically Adjusted PB Ratio?

As of today (2024-06-19), Ortin Laboratories's current share price is ₹20.63. Ortin Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹31.13. Ortin Laboratories's Cyclically Adjusted PB Ratio for today is 0.66.

The historical rank and industry rank for Ortin Laboratories's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:539287' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.44   Med: 0.66   Max: 1.06
Current: 0.61

During the past years, Ortin Laboratories's highest Cyclically Adjusted PB Ratio was 1.06. The lowest was 0.44. And the median was 0.66.

BOM:539287's Cyclically Adjusted PB Ratio is ranked better than
84.44% of 752 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs BOM:539287: 0.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ortin Laboratories's adjusted book value per share data for the three months ended in Mar. 2024 was ₹3.473. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹31.13 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ortin Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ortin Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Laboratories Cyclically Adjusted PB Ratio Chart

Ortin Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.74 0.66 0.52 0.57

Ortin Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 - 0.59 - 0.57

Competitive Comparison of Ortin Laboratories's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Laboratories's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ortin Laboratories's Cyclically Adjusted PB Ratio falls into.



Ortin Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ortin Laboratories's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=20.63/31.13
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ortin Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Ortin Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.473/153.0345*153.0345
=3.473

Current CPI (Mar. 2024) = 153.0345.

Ortin Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 94.103 0.000
201409 28.338 96.780 44.810
201412 0.000 96.780 0.000
201503 27.595 97.163 43.463
201506 0.000 99.841 0.000
201509 28.990 101.753 43.600
201512 0.000 102.901 0.000
201603 28.157 102.518 42.031
201606 0.000 105.961 0.000
201609 30.042 105.961 43.388
201612 0.000 105.196 0.000
201703 29.104 105.196 42.339
201706 0.000 107.109 0.000
201709 29.468 109.021 41.365
201712 0.000 109.404 0.000
201803 29.611 109.786 41.276
201806 0.000 111.317 0.000
201809 29.224 115.142 38.841
201812 0.000 115.142 0.000
201903 30.861 118.202 39.955
201906 0.000 120.880 0.000
201909 30.170 123.175 37.484
201912 0.000 126.235 0.000
202003 29.289 124.705 35.943
202006 0.000 127.000 0.000
202009 32.114 130.118 37.770
202012 0.000 130.889 0.000
202103 13.965 131.771 16.219
202106 0.000 134.084 0.000
202109 14.148 135.847 15.938
202112 0.000 138.161 0.000
202203 13.475 138.822 14.855
202206 0.000 142.347 0.000
202209 13.051 144.661 13.806
202212 0.000 145.763 0.000
202303 13.362 146.865 13.923
202306 0.000 150.280 0.000
202309 12.003 151.492 12.125
202312 0.000 152.924 0.000
202403 3.473 153.035 3.473

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ortin Laboratories  (BOM:539287) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ortin Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ortin Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Laboratories (BOM:539287) Business Description

Traded in Other Exchanges
Address
Street no. 3, D. No. 1-8-B4, Ground Floor,Block-4, F3 HIG, Baghlingampally, Hyderabad, TG, IND, 500 044
Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.

Ortin Laboratories (BOM:539287) Headlines

No Headlines